Lakefront Biotherapeutics N.V. ( LKFT) - Key Metrics
LKFT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.17 | $0.03 | $0 | $0 |
| 2026Q1 | $0.10 | $0.22 | -$1.26 | -$1.26 |
| 2025Q4 | $13.67 | $11.87 | -$0.72 | -$0.74 |
| 2025Q3 | $1.08 | -$3.07 | -$0.95 | -$0.99 |
| 2025Q2 | $0.99 | -$1.60 | -$1.65 | -$1.71 |
LKFT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 214.39 |
| 2026Q1 | 0% | 29.49 |
| 2025Q4 | 0% | 0.59 |
| 2025Q3 | 0% | -2.40 |
| 2025Q2 | 0% | -3.71 |
LKFT
Price: $28.49
52 week price:
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.9 billion